A. Early (prophylactic) surfactant administration, compared with delayed or selective rescue therapy, has been associated with lower combined rates of bronchopulmonary dysplasia (chronic lung disease) or death in preterm infants [Soll, 2001, PMID 11687026; Rojas-Reyes, 2012, PMID 23152225].